EP-1171 Blood parameters as prognosticators in radiochemotherapy for non-small cell lung cancer

Autor: Suwinski, R., Giglok, M., Galwas-Kliber, K., Dworzecka, U., Jochymek, B., Butkiewicz, D., Tukiendorf, A., Maslyk, B.

Publikováno v: In Radiotherapy and Oncology April 2015 115 Supplement 1:S636-S637

Ocena skuteczności mobilizacji komórek krwiotwórczych we krwi obwodowej oraz w produkcie leukaferezy z wykorzystaniem zautomatyzowanej metody RF/DC

Autor: Gliwińska, J., Masłyk, B., Kostecka, K., Chwieduk, A., Głowala-Kosińska, M., Fidyk, W., Saduś-Wojciechowska, M., Giebel, S.

Publikováno v: In Acta Haematologica Polonica July-September 2013 44 Supplement 1:157-157

The Role of Biochemical Markers in Prediction of Radiation Therapy Failure for Patients With Head-and-Neck Cancer

Autor: Rutkowski, T., Mrochem-Kwarciak, J., Masłyk, B., Hajduk, A., Wygoda, A., Lukaszczyk-Wideł, B., Hejduk, B., Hutnik, M., Goleń, M., Składowski, K.

Publikováno v: In International Journal of Radiation Oncology, Biology, Physics 1 November 2012 84(3) Supplement:S710-S710

The VEGFR2, COX-2 and MMP-2 polymorphisms are associated with clinical outcome of patients with inoperable non-small cell lung cancer.

Autor: Butkiewicz D; Center for Translational Research and Molecular Biology of Cancer, M. Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland., Krześniak M; Center for Translational Research and Molecular Biology of Cancer, M. Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland., Drosik A; II Clinic of Radiotherapy and Chemotherapy, M. Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland.; Department of Clinical Oncology, M. Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland., Giglok M; II Clinic of Radiotherapy and Chemotherapy, M. Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland., Gdowicz-Kłosok A; Center for Translational Research and Molecular Biology of Cancer, M. Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland., Kosarewicz A; Center for Translational Research and Molecular Biology of Cancer, M. Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland., Rusin M; Center for Translational Research and Molecular Biology of Cancer, M. Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland., Masłyk B; Department of Analytics and Clinical Biochemistry, M. Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland., Gawkowska-Suwińska M; III Clinic of Radiotherapy and Chemotherapy, M. Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland., Suwiński R; II Clinic of Radiotherapy and Chemotherapy, M. Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland.

Publikováno v: International journal of cancer [Int J Cancer] 2015 Nov 15; Vol. 137 (10), pp. 2332-42. Date of Electronic Publication: 2015 Jun 03.

Analysis of MMP-2 -735C/T (rs2285053) and MMP-9 -1562C/T (rs3918242) Polymorphisms in the Risk Assessment of Developing Lung Cancer.

Autor: Wadowska, Katarzyna¹ (AUTHOR) katarzyna.wadowska@student.umw.edu.pl, Błasiak, Piotr^2,3 (AUTHOR) adam.rzechonek@gmail.com, Rzechonek, Adam³ (AUTHOR), Śliwińska-Mossoń, Mariola¹ (AUTHOR) mariola.sliwinska-mosson@umw.edu.pl

Publikováno v: International Journal of Molecular Sciences. Jul2023, Vol. 24 Issue 13, p10576. 20p.